Charles Schwab’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.6M Buy
305,440
+54,628
+22% +$3.16M ﹤0.01% 1594
2025
Q4
$10.3M Buy
250,812
+57,753
+30% +$2.24M ﹤0.01% 2127
2025
Q3
$7.6M Buy
193,059
+28,746
+17% +$735K ﹤0.01% 2239
2025
Q2
$3.06M Sell
164,313
-3,789
-2% -$71.1K ﹤0.01% 2532
2025
Q1
$3.05M Buy
168,102
+1,081
+0.6% +$23.8K ﹤0.01% 2474
2024
Q4
$3.64M Buy
167,021
+1,092
+0.7% +$28.1K ﹤0.01% 2485
2024
Q3
$4.54M Buy
165,929
+97,362
+142% +$2.71M ﹤0.01% 2422
2024
Q2
$1.77M Buy
+68,567
New +$1.65M ﹤0.01% 2741
2023
Q3
Sell
-1,711
Closed -$20.7K 3587
2023
Q2
$20.7K Hold
1,711
﹤0.01% 3556
2023
Q1
$21.8K Hold
1,711
﹤0.01% 3501
2022
Q4
$10.8K Hold
1,711
﹤0.01% 3527
2022
Q3
$39K Buy
+1,711
New +$46.8K ﹤0.01% 3389
2022
Q2
Sell
-5,572
Closed -$259K 3565
2022
Q1
$259K Buy
5,572
+381
+7% +$20.8K ﹤0.01% 3256
2021
Q4
$368K Hold
5,191
﹤0.01% 3243
2021
Q3
$605K Buy
5,191
+517
+11% +$60.2K ﹤0.01% 3075
2021
Q2
$732K Buy
4,674
+1,258
+37% +$231K ﹤0.01% 3038
2021
Q1
$648K Buy
3,416
+239
+8% +$40.2K ﹤0.01% 2999
2020
Q4
$399K Hold
3,177
﹤0.01% 3061
2020
Q3
$346K Buy
3,177
+400
+14% +$47.4K ﹤0.01% 2986
2020
Q2
$334K Sell
2,777
-252
-8% -$35.5K ﹤0.01% 2994
2020
Q1
$305K Buy
3,029
+1
+0% +$185 ﹤0.01% 2889
2019
Q4
$735K Hold
3,028
﹤0.01% 2693
2019
Q3
$498K Buy
3,028
+328
+12% +$62.3K ﹤0.01% 2804
2019
Q2
$638K Buy
2,700
+700
+35% +$173K ﹤0.01% 2714
2019
Q1
$527K Buy
2,000
+1,190
+147% +$205K ﹤0.01% 2746
2018
Q4
$74K Buy
+810
New +$110K ﹤0.01% 3111

Other funds holding DNTH